M
Mario Fernández-Ruiz
Researcher at Complutense University of Madrid
Publications - 278
Citations - 6977
Mario Fernández-Ruiz is an academic researcher from Complutense University of Madrid. The author has contributed to research in topics: Transplantation & Medicine. The author has an hindex of 36, co-authored 244 publications receiving 4954 citations. Previous affiliations of Mario Fernández-Ruiz include Carlos III Health Institute.
Papers
More filters
Journal ArticleDOI
Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance
Mario Fernández-Ruiz,Mireia Puig-Asensio,Jesús Guinea,Benito Almirante,Belén Padilla,Manuel Almela,Ana Díaz-Martín,Jesús Rodríguez-Baño,Manuel Cuenca-Estrella,José María Aguado +9 more
TL;DR: C. tropicalis BSI was associated with advanced age, haematological malignancy and respiratory comorbidity, and there was no correlation between the unexpectedly high resistance rate to azoles observed and outcome.
Journal ArticleDOI
Comparison of the clinical course of Clostridium difficile infection in glutamate dehydrogenase-positive toxin-negative patients diagnosed by PCR to those with a positive toxin test
Julia Origüen,Laura Corbella,María Ángeles Orellana,Mario Fernández-Ruiz,Francisco López-Medrano,R. San Juan,Manuel Lizasoain,Tamara Ruiz-Merlo,Alejandra Morales-Cartagena,G. Maestro,Patricia Parra,J. Villa,Rafael Delgado,José María Aguado +13 more
TL;DR: Toxin-positive patients were more likely to have severe-complicated forms of CDI and recurrences, and CDI-related complications may still occasionally occur among toxin-negative patients diagnosed by PCR, which stresses the need for individualized clinical evaluation.
Journal ArticleDOI
Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study.
Mario Fernández-Ruiz,Francisco López-Medrano,María Asunción Pérez-Jacoiste Asín,Guillermo Maestro de la Calle,Héctor Bueno,José Manuel Caro-Teller,Mercedes Catalán,Cristina de la Calle,Rocío García-García,Carlos Mario Gómez Gómez,Rocío Laguna-Goya,Manuel Lizasoain,Joaquin Martinez-Lopez,Julia Origüen,José L. Pablos,Mar Ripoll,Rafael San Juan,Hernando Trujillo,Carlos Lumbreras,José María Aguado +19 more
TL;DR: In this observational single‐center study, TCZ appeared to be useful and safe as immunomodulatory therapy for severe COVID‐19 pneumonia.
Journal ArticleDOI
Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey.
David Navarro,Rafael San-Juan,Oriol Manuel,Estela Giménez,Mario Fernández-Ruiz,Hans H. Hirsch,Hans H. Hirsch,Paolo Grossi,José María Aguado +8 more
TL;DR: Information is gathered on current practices in the management of CMV infection across European centers in the era of molecular testing assays for active cytomegalovirus infection monitoring in solid organ transplant recipients.
Journal ArticleDOI
Cytomegalovirus Myopericarditis and Hepatitis in an Immunocompetent Adult: Successful Treatment with Oral Valganciclovir
Mario Fernández-Ruiz,Carolina Muñoz-Codoceo,Francisco López-Medrano,Regina Faré-García,Amparo Carbonell-Porras,Cristina Garfia-Castillo,Raquel Muñoz-Gómez,Jose María Aguado-García +7 more
TL;DR: A previously healthy 32-year-old man with primary CMV infection is presented with a case of acute myopericarditis and hepatitis, assessed by serology and positive pp65 antigenemia and successfully treated with a course of oral valganciclovir therapy.